Providing Tools for Effective Care and Treatment of Anxiety Disorders

NCT02605668 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 726

Last updated 2019-09-16

No results posted yet for this study

Summary

PROTECT-AD is a cognitive behavioral treatment study involving highly qualified psychotherapeutic centers at seven German universities.

It is our goal to further investigate and optimize existing effective treatments of anxiety disorders. In order to achieve this, the investigators want to investigate the effect of extinction learning in an "intensified" psychological intervention on treatment outcome in adults and children with anxiety disorders.

The intensified psychological intervention is characterized by a higher number of exposure trials over a short time period. In the control condition the exposure trials take place in a weekly interval, analog to standard care.

Conditions

Interventions

BEHAVIORAL

Intensified psychological intervention

12 sessions of Cognitive Behavioral Therapy a 100 minutes, over the course of 6 weeks (2 sessions per week/week 1 and 2, 3 sessions per week/week 3 und 4, 1 session per week/week 5 and 6)

BEHAVIORAL

Standard intervention

12 sessions of Cognitive Behavioral Therapy a 100 minutes, over the course of 10 weeks (2 sessions per week/week 1 and 2, 1 session per week/week 3 to 10)

Sponsors & Collaborators

  • Ruhr University of Bochum

    collaborator OTHER
  • University Medicine Greifswald

    collaborator OTHER
  • Charite University, Berlin, Germany

    collaborator OTHER
  • University of Wuerzburg

    collaborator OTHER
  • Philipps University Marburg

    collaborator OTHER
  • Wuerzburg University Hospital

    collaborator OTHER
  • Universität Münster

    collaborator OTHER
  • Technische Universität Dresden

    lead OTHER

Principal Investigators

  • Hans-Ulrich Wittchen, Ph.D. · Technische Universität Dresden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-12
Primary Completion
2019-07-24
Completion
2019-07-24

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02605668 on ClinicalTrials.gov